Company Overview: Prospect Prediction Markets Inc. (TSXV: MKT) operates a sports-focused prediction market platform that enables users to trade peer-to-peer on the outcomes of sporting events. The company covers major global sports leagues as well as niche competitions, leveraging real-time sports data and an interactive second-screen experience to facilitate market participation. Humacyte, Inc. (NASDAQ: HUMA) is a biotechnology company focused on developing innovative bioengineered human tissues, advanced tissue constructs, and organ systems for medical applications. The company leverages its proprietary tissue-engineering platform to develop universally implantable biological solutions designed to address unmet medical needs, improve patient outcomes, and advance the treatment of various medical conditions. This Report covers the Price Action, Technical Indicators Analysis along with the Stop Loss Levels, Target Prices, and Recommendations on these two stocks.

Global Markets Wrap-Up

U.S. equity markets ended the week on a positive note, with all three major indices closing in positive territory. The Nasdaq Composite outperformed the broader market, advancing 3.20% to close at 25,366.09, while the S&P 500 Index edged higher by 0.60% to finish at 7,592.40. Meanwhile, the Russell 2000 Index gained 1.63%, settling at 2,799.06, reflecting broad-based strength across U.S. equity markets.

Canada’s S&P/TSX Venture Composite Index declined 2.34% on a week-to-date basis to close at 802.78, indicating continued weakness in the broader market. Gains in the financials sector provided some selective support, reflecting pockets of buying interest. However, losses across the energy, healthcare, technology, basic materials, consumer cyclicals, and industrials sectors weighed on overall market performance. The mixed sectoral trend highlights a cautious investment environment, with investor sentiment remaining sensitive to macroeconomic uncertainty, changing economic expectations, and fluctuations in risk appetite.

Past performance is not a reliable indicator of future performance.